Webcasts / Podcasts from the 2008 AAPS Annual Meeting and Exposition
Recorded at the Georgia World Convention Center
Note: All media content contained herein, including mention of products and services, is the opinion
of the original presenters and is not necessarily endorsed by AAPS. Content discussing legal issues is
offered as general information only and is not to be construed as specific legal advice.
Formats available: (depending on presentation):
Video: Synchronized PowerPoint™ slides with audio lecture in Windows Media (wmv) format
Podcasts: Audio files of recorded lecture material in mp3 format
Slides: Presenters’ lecture slides in Adobe Acrobat pdf format
Free Webcasts:
- The Keynote Address
Challenges in Pediatric Drug Development, William E. Evans, D.Sc., Pharm.D., St. Jude Children’s Research Hospital.
Video (27 min.) |
Slides |
Podcast
- Plenary Session: Selected presentations
-
Searching for Genomic Biomarkers of Drug Risk in Children, Dr. Bruce Carleton, University of British Columbia
Video (32 min.) |
Podcast
-
Pediatric Drug Development, Anne Zajicek, M.D., Ph.D., Nat’l Institute for Child Health and Human Development
Video (25 min.) |
Podcast
- Town Hall Meeting
The Role of Pharmaceutical Sciences in Global Health
Podcast (60 min)
- The 2009 AAPS President’s Address
Patrick DeLuca, Ph.D.
Video (13 min) |
Slides |
Podcast
- The 2008 Outgoing AAPS President’s Address
Karen Habucky, Ph.D.
Video (12 min) |
Slides |
Podcast
- SPOD Roundtable: Training Pharmaceutical Scientists for the Future: Consider a Career in Academia
-
Current Academic Climate in Pharmacy, Kenneth W. Miller, Ph.D., American Assn. of Colleges of Pharmacy
Video (12 min) |
Slides |
Podcast
-
Academic Careers – Research Intensive University, Bo Michniak-Kohn, Ph.D., M.R., Pharm.S., Rutgers Univ.
Video (29 min) |
Slides |
Podcast
-
Academic Careers – Teaching Intensive University, Nita Pandit, Ph.D., Drake University
Video (12 min) |
Slides |
Podcast
-
Q&A Session: Podcast
|
|
Fee-Based Short Courses:
The following Short Courses are fee-based and are available individually. Please click on the “REGISTER”
button below each title for payment information and a form to be faxed in to AAPS. Upon receipt of payment, you will
receive a special URL, username and password. To view content, enter the URL provided and insert the access codes
provided in lieu of your member login.
Attendees, presenters and moderators of the 2008 AAPS Annual Meeting and Exposition in Atlanta may view all fee-based
events listed below at no charge, upon receipt of registration form.
Metabolites Data as a Prerequisite for Regulatory Submissions: Current Practice, Challenges and Case Studies
In 2008, the FDA issued the Guidance for Industry: Safety Testing of Drug Metabolites providing current
regulatory perspective on the testing of metabolites for new drugs. In parallel, the sensitivity and availability
of analytical tools used to isolate and identify metabolites has dramatically increased. Thus, expectation to
identify characterization and synthesize drug metabolites in order to understand their potential clinical and
toxicological impact has increased substantially since the draft Guidance was released in 2005. How extensively
and at what stage of drug development should metabolites be characterized continues to be a challenge for both
regulatory agencies and the pharmaceutical industry. This short course will introduce the current regulatory and
industry perspectives on metabolite characterization, highlight the analytical challenges to identifying metabolites,
and provide case studies describing the decisions made in characterizing metabolites for an investigational drug.
- Interpretation of Current and Future Practice for Metabolite Characterization
Aisar Atrakchi, Ph.D., U.S. Food and Drug Administration
- Radiolabeled Mass Balance Studies: Objectives, Utility and Limitations
Chandra Prakash, Ph.D. Biogen Idec
- Metabolite Identification Strategies in Discovery and Development
Angus Nedderman, Ph.D., Pfizer Global R&D
- A Process for Metabolite Testing
Andy Ayrton, Ph.D., GlaxoSmithKline
|
Pharmacodynamic Modeling of Non-Standard Endpoints
- Binary Data
Scott Patterson, Ph.D., Wyeth
- Nominal and Ordinal Data
Brian Smith, Ph.D., Amgen, Inc.
- Modeling Count Data
Raymond Miller, DSc., Pfizer, Inc.
- Modeling Time to Event Data
Peter L. Bonate, Ph.D., FCP, Genzyme Corporation
- Generalized Linear Models and Extensions
José C. Pinheiro, Ph.D., Novartis
|
|
 |
|
|